Acrónimos

FA · Fibrilación Auricular FACS · Find cases, Assess, Confirm, and Severity FADK · Food Addiction Denmark FAECAP · Federación de Asociaciones de Enfermería Familiar y Comunitaria FAERS · FDA's Adverse Event Reporting System FAH · Falta de AdHerencia FANV · Fibrilación Auricular No Valvular FAs · Fatty acids FDA · Food Drug Administration FDC · Fixed-dose combination FDPS · Finnish Diabetes Prevention Study FE · Fracción de Eyección FER/TOPI · fermetina/topiramato FEVI · Fracción de Eyección del Ventrículo Izquierdo FFQ · Food Frequency Questionnaire FGe · Filtrado Glomerular estimado FGF21 · Fibroblast Growth Factor 21 (factor de crecimiento de fibroblastos) FGm · FGe media FHA · Fibrosis Hepática Avanzada FHS · Framingham Heart Study FIB-4 · Indice de Fibrosis-4 FIDELIO-DKD · Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease FIDELITY · Finerenone Cuts CV Risk in T2D Across CKD Spectrum FIELD · Fenofibrate Intervention and Event Lowering in Diabetes FIGARO-DKD · Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease FIGHT · Functional Impact of GLP-1 for Heart Failure Treatment FIM · Food is Medicine FINE-HEART · FINE-HEART Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes FINE-REAL · Finerenona en un entorno de atención médica de rutina FINEARTS-HF · Finerenone in Heart Failure with Mildly Reduced and Preserved Ejection Fraction Heart Failure According to Diabetes Status FINEARTS-HF · Finerenone in Heart Failure with Mildly Reduced and Preserved Ejection Fraction Heart Failure According to Diabetes Status FLI · Fatty Liver Index FLOW · Evaluate Renal Function With Semaglutide Once Weekly FND-CKD · Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (eficacia y la seguridad de la finerenona en adultos con enfermedad renal crónica sin diabetes) FO · Fondo de Ojo FOCUS · Long-term Effects of Semaglutide on Diabetic Retinopathy in Subjects With Type 2 Diabetes FORCE · Fatty Acids and Outcomes Research Consortium FOURIER · Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Fr1da · Früherkennung de Typ 1 Diabetes (Detección Temprana de la Diabetes Tipo 1) FRA · Factor de Riesgo Atribuible FRCM · Factor de Riesgo CardioMetabólico FRCV · Factor de Riesgo Cardiovascular FSH · Hormona Estimulante del Folículo